These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 8128423

  • 1. [Pharmacokinetic changes in obesity].
    Girardin E, Bruguerolle B.
    Therapie; 1993; 48(4):397-402. PubMed ID: 8128423
    [Abstract] [Full Text] [Related]

  • 2. Influence of obesity on drug disposition.
    Blouin RA, Kolpek JH, Mann HJ.
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
    Cheymol G.
    Bull Acad Natl Med; 1990 Oct; 174(7):959-67; discussion 967-8. PubMed ID: 1981983
    [Abstract] [Full Text] [Related]

  • 4. Anesthesia in the obese patient: pharmacokinetic considerations.
    Casati A, Putzu M.
    J Clin Anesth; 2005 Mar; 17(2):134-45. PubMed ID: 15809132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antimicrobial dosing considerations in obese adult patients.
    Pai MP, Bearden DT.
    Pharmacotherapy; 2007 Aug; 27(8):1081-91. PubMed ID: 17655508
    [Abstract] [Full Text] [Related]

  • 8. Drug pharmacokinetics in the obese.
    Cheymol G.
    Fundam Clin Pharmacol; 1988 Aug; 2(3):239-56. PubMed ID: 3042569
    [Abstract] [Full Text] [Related]

  • 9. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women.
    Polak J, Klimcakova E, Moro C, Viguerie N, Berlan M, Hejnova J, Richterova B, Kraus I, Langin D, Stich V.
    Metabolism; 2006 Oct; 55(10):1375-81. PubMed ID: 16979409
    [Abstract] [Full Text] [Related]

  • 10. Drug Distribution in Obesity and following Bariatric Surgery: A Literature Review.
    Macgregor AM, Boggs L.
    Obes Surg; 1996 Feb; 6(1):17-27. PubMed ID: 10731246
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M.
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [Abstract] [Full Text] [Related]

  • 13. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
    Kolehmainen M, Vidal H, Alhava E, Uusitupa MI.
    Obes Res; 2001 Nov; 9(11):706-12. PubMed ID: 11707537
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of theophylline in obesity.
    Zahorska-Markiewicz B, Waluga M, Zieliñski M, Klin M.
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):393-5. PubMed ID: 8880289
    [Abstract] [Full Text] [Related]

  • 15. Effect of fat distribution on the pharmacokinetics of cortisol in obesity.
    Lottenberg SA, Giannella-Neto D, Derendorf H, Rocha M, Bosco A, Carvalho SV, Moretti AE, Lerário AC, Wajchenberg BL.
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):501-5. PubMed ID: 9760012
    [Abstract] [Full Text] [Related]

  • 16. Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studies.
    Barre J, Urien S, Albengres E, Tillement JP.
    Xenobiotica; 1988 Jan; 18 Suppl 1():15-20. PubMed ID: 3344588
    [Abstract] [Full Text] [Related]

  • 17. [Body fat distribution: its characteristics and relationship to cardiovascular risk factors in obese Chinese].
    Ran XW, Li XS, Tong NW, Li QF, Tang BD, Li XJ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):699-703. PubMed ID: 15460424
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice.
    Lee MS, Kim CT, Kim Y.
    Ann Nutr Metab; 2009 Sep; 54(2):151-7. PubMed ID: 19390166
    [Abstract] [Full Text] [Related]

  • 20. Effect of obesity on the pharmacokinetics of drugs in humans.
    Hanley MJ, Abernethy DR, Greenblatt DJ.
    Clin Pharmacokinet; 2010 Sep; 49(2):71-87. PubMed ID: 20067334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.